Table 1.
Baseline characteristics of glioma patients in TCGA
| Clinical Characteristics | All | High risk | Low risk | p-value |
|---|---|---|---|---|
| No. | 476 | 161 | 315 | - |
| Age, median (IQR) | 41 (33 to 53) | 47 (35 to 59) | 39 (32 to 49) | <0.001 |
| Gender, No. (%) | ||||
| Female | 216 (45%) | 69 (42.86%) | 147 (46.67%) | 0.43 |
| Male | 260 (55%) | 92 (57.14%) | 168 (53.33%) | |
| Grade, No. (%) | ||||
| G2 | 231 (49%) | 47 (29.19%) | 184 (58.41%) | <0.001 |
| G3 | 245 (51%) | 114 (70.81%) | 131 (41.59%) | |
| Futime, median (IQR) | 590 (375 to 1105.5) | 546(326 to 915) | 622 (407 to 1164) | 0.0363 |
| Fustat, No. (%) | ||||
| Live | 369 (78%) | 96 (59.63%) | 273 (86.67%) | <0.001 |
| Death | 107 (22%) | 65 (40.37%) | 42 (13.33%) |
Note: IQR, interquartile range; Futime, survival time; Fustat, survival state. p-value: p value represents the difference of clinical characteristics between high and low risk groups.